Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

Xianghua Zeng; Shicong Zhu; Cheng Xu; Zhongyu Wang; Xingxing Su; Dong Zeng; Haixia Long; Bo Zhu

doi:10.12659/MSM.922576

07 September 2020 : Clinical Research

Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

Xianghua Zeng^123CDEG, Shicong Zhu^12BCD, Cheng Xu^4CF, Zhongyu Wang^12CD, Xingxing Su^12CD, Dong Zeng^12CD, Haixia Long^12AF*, Bo Zhu^12AG

DOI: 10.12659/MSM.922576

Med Sci Monit 2020; 26:e922576

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 2 The simplified comorbidity score weights.

Weight	Comorbidity conditions
1 point	Respiratory diseases; cardiovascular diseases; alcoholism; neoplastic comorbidity
4 points	Renal insufficiency
5 points	Diabetes mellitus
7 points	Tobacco consumption
17 points	Maximum comorbidity score

Back to the Article

Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

Your Privacy